.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Chinese Patent Office
Covington
Fish and Richardson
Accenture
Dow
Federal Trade Commission
Merck
Daiichi Sankyo

Generated: December 18, 2017

DrugPatentWatch Database Preview

CEFMAX Drug Profile

« Back to Dashboard

When do Cefmax patents expire, and when can generic versions of Cefmax launch?

Cefmax is a drug marketed by Tap Pharm and is included in one NDA.

The generic ingredient in CEFMAX is cefmenoxime hydrochloride. There is one drug master file entry for this compound. Additional details are available on the cefmenoxime hydrochloride profile page.
Drug patent expirations by year for CEFMAX

Medical Subject Heading (MeSH) Categories for CEFMAX

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tap PharmCEFMAXcefmenoxime hydrochlorideINJECTABLE;INJECTION050571-002Dec 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Tap PharmCEFMAXcefmenoxime hydrochlorideINJECTABLE;INJECTION050571-003Dec 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Tap PharmCEFMAXcefmenoxime hydrochlorideINJECTABLE;INJECTION050571-001Dec 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chubb
Cantor Fitzgerald
Fish and Richardson
Queensland Health
Covington
Dow
Chinese Patent Office
Federal Trade Commission
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot